Efficacy and safety of vildagliptin and voglibose in Japanese patients with type 2 diabetes: a 12-week, randomized, double-blind, active-controlled study

Aim: To confirm the efficacy of vildagliptin in patients with type 2 diabetes (T2D) by testing the hypothesis that glycosylated haemoglobin (HbA1c) reduction with vildagliptin is superior to that with voglibose after 12 weeks of treatment. Methods: In this 12-week, randomized, double-blind, active-c...

Full description

Saved in:
Bibliographic Details
Main Authors: Iwamoto, Y, Kashiwagi, A, Yamada, N, Terao, S, Mimori, N, Suzuki, M, Tachibana, H
Format: Artigo
Language:Inglês
Published: Blackwell Publishing Ltd 2010
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2916214/
https://ncbi.nlm.nih.gov/pubmed/20590747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1463-1326.2010.01222.x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items